The nurse cares for a client in the hospital Review the electronic health record. Complete the diagram by dragging from the choices below to specify what condition the client is most likely experiencing, two actions the nurse should take to address that condition, and two parameters the nurse should monitor to assess the client's progress.

This case focuses on recognizing vancomycin infusion-related reaction, commonly called “Red Man Syndrome” or vancomycin flushing syndrome. It occurs due to rapid infusion of vancomycin causing non–IgE-mediated histamine release, leading to flushing, erythema, pruritus, and sometimes hypotension. It is not a true allergy but a rate-related infusion reaction. Differentiating it from anaphylaxis and severe cutaneous adverse reactions is essential for appropriate management. Rationale for correct choices: • Vancomycin flushing syndrome: The client developed erythematous rash involving the face, neck, chest, and arms immediately after completion of vancomycin infusion, along with mild itching. This timing and presentation strongly indicate vancomycin flushing syndrome, which is related to rapid infusion rather than immune-mediated anaphylaxis. There is no evidence of airway compromise, angioedema, or multisystem collapse. The presentation is classic for histamine-mediated reaction secondary to vancomycin administration rate. • Call provider to clarify future vancomycin administration rate: Management of vancomycin flushing syndrome primarily involves slowing the infusion rate or adjusting future dosing schedules. The provider must be notified to modify administration parameters to prevent recurrence. This intervention directly addresses the cause of histamine release. It is a key preventive action rather than an emergency resuscitation measure. • Administer diphenhydramine 50 mg PO: Diphenhydramine is an antihistamine that helps counteract histamine-mediated symptoms such as flushing, itching, and rash. It is appropriate for mild to moderate vancomycin flushing syndrome. This medication helps reduce symptom severity and improves patient comfort. It does not replace the need to adjust infusion rate but supports symptomatic management. • Presence of wheezing: Wheezing is important to monitor because it may indicate progression toward more severe histamine-mediated airway involvement. Although not present initially, respiratory symptoms can develop if the reaction worsens. Monitoring for wheezing helps detect early airway compromise. It is a key indicator of potential escalation of the reaction. • Frequent blood pressure readings: Blood pressure monitoring is essential because histamine release can cause vasodilation leading to hypotension in more severe cases. Although vancomycin flushing syndrome is typically mild, monitoring ensures early detection of hemodynamic instability. Blood pressure trends help differentiate between mild infusion reaction and evolving anaphylaxis. It is a critical safety parameter. Rationale for incorrect action choices: • Anaphylactic reaction: Anaphylaxis is an IgE-mediated, life-threatening allergic reaction that involves multiple body systems, especially respiratory and cardiovascular collapse. It typically presents with airway swelling, wheezing, stridor, hypotension, and possible loss of consciousness. In this case, the client has isolated erythema and itching without airway compromise or systemic instability. The reaction occurred after vancomycin infusion and is consistent with a rate-related histamine response rather than immune-mediated anaphylaxis. • Stevens-Johnson syndrome (SJS): Stevens-Johnson syndrome is a severe mucocutaneous reaction characterized by widespread skin detachment, mucosal involvement, blistering, and systemic symptoms such as fever and malaise. It usually develops over days to weeks after exposure to a triggering medication. This client has acute flushing and erythema immediately after infusion, with no mucosal lesions or skin sloughing making SJS unlikely. • Toxic epidermal necrolysis (TEN): TEN is a life-threatening progression of Stevens-Johnson syndrome involving extensive epidermal detachment and severe mucosal involvement. It presents with widespread blistering, skin pain, and systemic toxicity, typically developing gradually after drug exposure. The client in this case has no skin breakdown, blistering, or mucosal involvement. The presentation is localized erythema and itching occurring immediately post-infusion, which is not consistent with TEN. • Administer IM epinephrine: Epinephrine is indicated for anaphylaxis, not vancomycin flushing syndrome. This client does not show signs of airway compromise, bronchospasm, or cardiovascular collapse. The reaction is limited to skin flushing and mild itching following infusion completion. Therefore, epinephrine is not warranted and would be excessive for this condition. • Prepare client for intubation: Intubation is reserved for severe anaphylaxis or airway obstruction. This client has no signs of airway swelling, stridor, or respiratory distress. Vancomycin flushing syndrome does not typically progress to airway compromise when managed appropriately. Therefore, airway intervention is not indicated at this stage. • Administer total parenteral nutrition: TPN is unrelated to the acute allergic or infusion reaction being experienced. The client’s condition is an acute medication-related histamine response, not a nutritional deficit or gastrointestinal failure. There is no indication for long-term nutritional support. Therefore, this intervention is not appropriate. • Oral mucosa lining: Assessment of oral mucosa is important in conditions like Stevens-Johnson syndrome or toxic epidermal necrolysis, where mucosal erosion is a key feature. However, vancomycin flushing syndrome does not involve mucosal damage. The client’s reaction is limited to skin flushing and pruritus without oral involvement. Therefore, this parameter is not a priority indicator for progression or severity in this condition. • Complaints of back pain: Back pain is not a characteristic feature of vancomycin flushing syndrome or allergic reactions to vancomycin. Although some infusion reactions may cause generalized discomfort, back pain is not a marker of severity or progression. It is more commonly associated with renal issues or other systemic conditions unrelated to histamine-mediated flushing. Therefore, it is not relevant for monitoring this reaction. • Complaints of dry eyes: Dry eyes are not associated with vancomycin flushing syndrome or acute infusion-related histamine reactions. This symptom is more relevant to chronic autoimmune conditions such as Sjögren syndrome or severe mucocutaneous disorders like Stevens-Johnson syndrome. In this case, the client’s symptoms are acute and cutaneous, not mucosal or glandular. Therefore, this is not a useful monitoring parameter.